Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $40.1 million.

  • Ironwood Pharmaceuticals' Income towards Parent Company rose 99928.69% to $40.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.5 million, marking a year-over-year increase of 15681.0%. This contributed to the annual value of $102.8 million for FY2024, which is 10816.89% up from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Income towards Parent Company is $40.1 million, which was up 99928.69% from $23.6 million recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Income towards Parent Company registered a high of $391.3 million during Q2 2021, and its lowest value of -$1.1 billion during Q2 2023.
  • For the 5-year period, Ironwood Pharmaceuticals' Income towards Parent Company averaged around -$22.4 million, with its median value being $38.8 million (2022).
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Income towards Parent Company tumbled by 303830.1% in 2023 and then soared by 284406.98% in 2025.
  • Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Income towards Parent Company stood at $41.4 million in 2021, then grew by 18.16% to $48.9 million in 2022, then plummeted by 567.15% to -$228.3 million in 2023, then surged by 145.63% to $104.2 million in 2024, then tumbled by 61.52% to $40.1 million in 2025.
  • Its Income towards Parent Company was $40.1 million in Q3 2025, compared to $23.6 million in Q2 2025 and -$37.4 million in Q1 2025.